When administered together with HMA (30 μM and 40 μM) for 24 h, NEC did not rescue HMA-induced cell death (Fig. 3b), thus suggesting that in HCT-116 cells RIPK1 is not involved in the cellular response to HMA, as already shown in breast cancer cells [9]. Here, RIPK1 is linked to breast cancer.